当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:147.77亿  总市值:172.03亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润14.50亿元,每股收益2.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2046588.87万元,未分配利润1196606.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产5073693.46万元,负债3027104.58万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入56,585,864,462.4338,387,531,548.0218,686,817,786.573,443,136,988.14
营业总成本54,981,233,258.6437,247,256,783.7818,166,841,198.471,309,688,406.13
营业利润1,822,923,220.31,295,113,233.31576,353,112.12,306,068,620.28
利润总额1,820,452,853.951,291,654,341.53578,487,139.582,311,070,116.47
净利润1,450,194,883.181,029,405,515.14460,830,788.651,771,737,990.91
其他综合收益-9,845.92-9,845.92-4,772.05-23,323,681.6
综合收益总额1,450,185,037.261,029,395,669.22460,826,016.61,748,414,309.31
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计39,698,248,883.7438,840,028,022.3136,929,433,752.5831,708,246,272.74
非流动资产合计11,038,685,690.5311,042,910,738.2810,955,764,183.9910,907,514,304.68
资产总计50,736,934,574.2749,882,938,760.5947,885,197,936.5742,615,760,577.42
流动负债合计28,071,671,339.5427,585,168,250.6225,911,745,135.7221,027,598,902.57
非流动负债合计2,199,374,507.312,203,592,198.752,086,534,965.372,143,455,005
负债合计30,271,045,846.8529,788,760,449.3727,998,280,101.0923,171,053,907.57
归属于母公司股东权益合计16,972,948,050.2516,613,532,160.8116,488,091,433.9416,125,890,447.68
股东权益合计20,465,888,727.4220,094,178,311.2219,886,917,835.4819,444,706,669.85
负债和股东权益合计50,736,934,574.2749,882,938,760.5947,885,197,936.5742,615,760,577.42
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计53,825,819,839.4535,311,862,263.3615,723,524,491.6681,658,219,950.88
经营活动现金流出小计52,360,350,737.7233,825,586,262.4315,513,539,023.3379,097,789,338.11
经营活动产生的现金流量净额1,465,469,101.731,486,276,000.93209,985,468.332,560,430,612.77
投资活动现金流入小计164,474,228.8385,294,587.161,807,753.7180,618,256.37
投资活动现金流出小计228,962,940.88157,899,817.8470,841,202.47523,437,313.89
投资活动产生的现金流量净额-64,488,712.05-72,605,230.68-69,033,448.77-342,819,057.52
筹资活动现金流入小计1,420,106,804.21715,518,573.15566,164,144.131,948,781,522.2
筹资活动现金流出小计3,434,757,444.842,125,198,114.71648,747,781.543,456,541,949.14
筹资活动产生的现金流量净额-2,014,650,640.63-1,409,679,541.56-82,583,637.41-1,507,760,426.94
汇率变动对现金及现金等价物的影响-943,922.9-956,595.89881.86-1,189,928.78
现金及现金等价物净增加额-614,614,173.853,034,632.858,369,264.01708,661,199.53
期末现金及现金等价物余额4,827,559,248.035,445,208,054.685,500,542,685.895,442,173,421.88
最新报告期:2024-03-18
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中金公司朱言音2.873.193.552024-03-18
国泰君安丁丹,张拓2.873.193.532024-03-15
TOP↑